Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Plasmablastic Lymphoma 1Lymphoma, T-Cell 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Hodgkin Disease 1HIV Infections 1Burkitt Lymphoma 1

Interventions

Cyclophosphamide 23Vincristine 16Prednisone 16Methotrexate 15prednylidene 13deltacortene 13blinatumomab 13merphos 12Specimen Handling 12Cytarabine 12N,N-dicyclohexyl-isoborneol-10-sulfonamide 10Mercaptopurine 10Doxorubicin 10Dexamethasone 10pegaspargase 9azathiopurine 9Etoposide 9Biopsy 9dexamethasone acetate 8dexamethasone 21-phosphate 8auricularum 8Spinal Puncture 8Rituximab 8Calcium Dobesilate 8venetoclax 7fludarabine 7Leucovorin 7Thioguanine 6Magnetic Resonance Spectroscopy 6Daunorubicin 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Burkitt Lymphoma × carmustine, poliferprosan 20 drug combination × 30 days × Clear all
NCT02797470 2026-05-18

Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant

AIDS Malignancy Consortium

Phase 1/2 Active not recruiting
11 enrolled 9 charts
Lymphoid

Plasmablastic Lymphoma, Burkitt Lymphoma, Hodgkin Disease, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, HIV Infections, Lymphoma, T-Cell, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡